Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Gains from Investment Securities (2020 - 2025)

IceCure Medical has reported Gains from Investment Securities over the past 6 years, most recently at $1.3 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 53.53% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, up 53.53%, while the annual FY2025 figure was $1.3 million, 53.53% up from the prior year.
  • Gains from Investment Securities was $1.3 million for Q4 2025 at IceCure Medical, up from $26000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $3.7 million in Q4 2023 and bottomed at $24635.0 in Q4 2021.
  • The 5-year median for Gains from Investment Securities is $463106.0 (2022), against an average of $1.0 million.
  • Year-over-year, Gains from Investment Securities plummeted 98.31% in 2021 and then soared 5778.13% in 2023.
  • Over 5 years, Gains from Investment Securities stood at $24635.0 in 2021, then skyrocketed by 156.8% to $63262.0 in 2022, then soared by 5778.13% to $3.7 million in 2023, then tumbled by 76.79% to $862950.0 in 2024, then surged by 53.53% to $1.3 million in 2025.
  • The last three reported values for Gains from Investment Securities were $1.3 million (Q4 2025), $26000.0 (Q1 2025), and $862950.0 (Q4 2024) per Business Quant data.